5Nagata Y, Lan KH, Zhou X, et al. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell, 2004,6 ( 2 ) : 117- 127.
3Association of Directors of Anatomic and Surgical Pathology: standardization of the surgical pathology report. Am J Surg Pathol, 1992,16( 1 ) :84-86.
4Conolly JL, Fechner RE, Kempson RL, et al. ADASP breast carcinoma guideline. Recommendations for the reporting of breast carcinoma. Association of Directors of Anatomic and Surgical Pathology [ EB/OL ]. Association of Directors of Anatomic and Surgical Pathology. ( 2004-9 ) [ 2008-5 ]. http://www, adasp. org/Checklists/checklists/BREAST% 20-% 20GUIDELINE% 20-%20vl. 1. odf.
5Fitzgibbons PL, Conolly JL, Page DL, et al. College of American Pathologists. Protocol applies to all invasive carcinomas of the breast [ EB/OL 1. ( 2005-1 ) [ 2008-5 ]. http ://www. cap. org,/ apps/docsdcommittees/cancer/cancer _ protocols/20OS/breastO5 _ ckw/pdf.
6Ellis IO, Pinder SE, Bobrow L, et al. NHS Cancer Screening Programmes. Pathology reporting of breast diseases [ EB/OL]. (2005-1) [ 2008-5 ]. http://www, cancerscreening, org. uk/ breastscreen/publications/nhsbsp58 -histopathology-reporting-form. pdf.
7Alexander F, Danyluk J, Greeff MP, et al. Public Health Agency of Canada. Guidelines for the pathological examination and reporting of breast specimens [ EB/OL]. ( 2002 ) [ 2008-5 ]. http ://www. phac-aspc, gc. ca/publicat/qdobcspJdqpodcs/appeng. php.
8ASWCS Breast Site Specialist Group. Breast cancer clinical care Guidelines [ EB/OL ]. Avon, Somerset and Wiltshire Cancer Services. (2005-11) [2008-5 ]. http://www, aswcs, nhs. uk/ sitespecgps/breast/'Breast% 20Cancer% 20Guidelines. pdf.
9British Columbia Cancer Agency. Breast Cancer-Pathology Reporting [ EB/OL ]. ( 2006-11 ) [ 2008-5 ]. http://www. bccancer, bc. ca/NR/rdonlyres/121CCFCF-536B-4C06-950B- 964B6CAAF2A3/18882/Checkhsfforpathologyreportingofbreastca- 2006Oct30. pdf.
10Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol, 2007,25 ( 33 ) : 5287-5312.
